![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, January 30, 2007 9:38:29 PM
I am surprised that the Mammoth article could have had any effect at all. That is certainly not a significant revenue generating deal which is really what the company needs to get the pps out of the crapper. All the hype and bruhaha that we've seen over the past year have been nothing but fluff and cannot increase the pps and sustain it at a respectable level. I am afraid all we have here is a trading vehicle for those skilled in that art.
The fact that no pr has issued from all that Merck/Moffitt noise confirming DNAG as a viable partner in the M2GEN deal leads me to believe no one is seriously considering what DNAG has to offer to be a viable personalized medicine contribution for the M2GEN objectives.
JMHO but I suppose time will tell.
dr f
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM